GAIN THERAPEUTICS, INC (GANX) Free cash flow 2021–2025
GAIN THERAPEUTICS, INC (GANX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$18.5MFY2025 · since FY2021: -$12.4M → -$18.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.5M | +2.1% |
| FY2024 | -$18.9M | +0.5% |
| FY2023 | -$19.0M | -28.4% |
| FY2022 | -$14.8M | -19.4% |
| FY2021 | -$12.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More GANX financial trends
GANX RevenueGANX Net incomeGANX Net marginGANX Gross profitGANX Gross marginGANX Operating incomeGANX Operating marginGANX Operating cash flowGANX Capital expendituresGANX Return on equityGANX Stock buybacksGANX Dividends paidGANX Total assetsGANX Total liabilitiesGANX Shareholders’ equityGANX overview →